Advertisement

Loading...

Columbia Care Inc.

CCHW.NENEO
Healthcare
Drug Manufacturers - Specialty & Generic
$1.72
$-0.01(-0.58%)
Canadian Market opens in 16h 35m

Columbia Care Inc. Fundamental Analysis

Columbia Care Inc. (CCHW.NE) shows weak financial fundamentals with a PE ratio of -1.17, profit margin of -81.32%, and ROE of -1.07%. The company generates $0.3B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.02

Areas of Concern

ROE-1.07%
Operating Margin-81.36%
We analyze CCHW.NE's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -203.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-203.4/100

We analyze CCHW.NE's fundamental strength across five key dimensions:

Efficiency Score

Weak

CCHW.NE struggles to generate sufficient returns from assets.

ROA > 10%
-41.82%

Valuation Score

Excellent

CCHW.NE trades at attractive valuation levels.

PE < 25
-1.17
PEG Ratio < 2
-0.02

Growth Score

Weak

CCHW.NE faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

CCHW.NE shows balanced financial health with some risks.

Debt/Equity < 1
2.74
Current Ratio > 1
1.17

Profitability Score

Weak

CCHW.NE struggles to sustain strong margins.

ROE > 15%
-106.90%
Net Margin ≥ 15%
-81.32%
Positive Free Cash Flow
No

Key Financial Metrics

Is CCHW.NE Expensive or Cheap?

P/E Ratio

CCHW.NE trades at -1.17 times earnings. This suggests potential undervaluation.

-1.17

PEG Ratio

When adjusting for growth, CCHW.NE's PEG of -0.02 indicates potential undervaluation.

-0.02

Price to Book

The market values Columbia Care Inc. at 2.34 times its book value. This may indicate undervaluation.

2.34

EV/EBITDA

Enterprise value stands at 0.77 times EBITDA. This is generally considered low.

0.77

How Well Does CCHW.NE Make Money?

Net Profit Margin

For every $100 in sales, Columbia Care Inc. keeps $-81.32 as profit after all expenses.

-81.32%

Operating Margin

Core operations generate -81.36 in profit for every $100 in revenue, before interest and taxes.

-81.36%

ROE

Management delivers $-1.07 in profit for every $100 of shareholder equity.

-1.07%

ROA

Columbia Care Inc. generates $-41.82 in profit for every $100 in assets, demonstrating efficient asset deployment.

-41.82%

Following the Money - Real Cash Generation

Operating Cash Flow

Columbia Care Inc. generates limited operating cash flow of $-67.19M, signaling weaker underlying cash strength.

$-67.19M

Free Cash Flow

Columbia Care Inc. generates weak or negative free cash flow of $-111.06M, restricting financial flexibility.

$-111.06M

FCF Per Share

Each share generates $-0.47 in free cash annually.

$-0.47

FCF Yield

CCHW.NE converts -62.98% of its market value into free cash.

-62.98%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.17

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.34

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.57

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

2.74

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.17

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.07

vs 25 benchmark

ROA

Return on assets percentage

-0.42

vs 25 benchmark

ROCE

Return on capital employed

-0.53

vs 25 benchmark

How CCHW.NE Stacks Against Its Sector Peers

MetricCCHW.NE ValueSector AveragePerformance
P/E Ratio-1.1727.91 Better (Cheaper)
ROE-106.90%687.00% Weak
Net Margin-81.32%-45285.00% (disorted) Weak
Debt/Equity2.740.33 Weak (High Leverage)
Current Ratio1.172795.76 Neutral
ROA-41.82%-13557.00% (disorted) Weak

CCHW.NE outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Columbia Care Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ